Paclitaxel as a radiation sensitizer for locally advanced pancreatic cancerSAFRAN, Howard; RATHORE, Ritesh.Critical reviews in oncology/hematology. 2002, Vol 43, Num 1, pp 57-62, issn 1040-8428Article

Carboplatin with weekly docetaxel and ifosfamide in advanced head and neck cancers: a phase I Brown University Oncology Group dose escalation study (HN-93)RATHORE, Ritesh; BIRNBAUM, Ariel; RATHORE, Bharti et al.Cancer chemotherapy and pharmacology. 2010, Vol 66, Num 6, pp 1013-1017, issn 0344-5704, 5 p.Article

Anti-CD3 x anti-epidermal growth factor receptor (EGFR) bispecific antibody redirects T-cell cytolytic activity to egfr-positive cancers in vitro and in an animal modelREUSCH, Ursula; SUNDARAM, Magesh; DAVOL, Pamela A et al.Clinical cancer research. 2006, Vol 12, Num 1, pp 183-190, issn 1078-0432, 8 p.Article

Cetuximab, Paclitaxel, Carboplatin, and Radiation for Head and Neck Cancer: A Survival Analysis of a Brown University Oncology Group Phase II StudyBIRNBAUM, Ariel; DIPETRILLO, Thomas; FOLLETT, Nancy et al.American journal of clinical oncology. 2014, Vol 37, Num 2, pp 162-166, issn 0277-3732, 5 p.Article

CONCURRENT CHEMORADIOTHERAPY WITH WEEKLY PACLITAXEL AND CARBOPLATIN FOR LOCALLY ADVANCED HEAD AND NECK CANCER : LONG-TERM FOLLOW-UP OF A BROWN UNIVERSITY ONCOLOGY GROUP PHASE II STUDY (HN-53)CHOUGULE, Prakash B; AKHTAR, Muhammad S; RATHORE, Ritesh et al.Head & neck. 2008, Vol 30, Num 3, pp 289-296, issn 1043-3074, 8 p.Article

Overexpression of the HER-2/neu oncogene in pancreatic adenocarcinomaSAFRAN, Howard; STEINHOFF, Margaret; PASQUARIELLO, Terese et al.American journal of clinical oncology. 2001, Vol 24, Num 5, pp 496-499, issn 0277-3732Conference Paper